Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Latex Allergy Companies

Latex allergy refers to an allergic reaction to proteins present in natural rubber latex, a material derived from the sap of the rubber tree. Latex is commonly used in various products, including gloves, medical devices, and household items. Companies that focus on latex allergy typically work towards providing alternatives or addressing the needs of individuals with latex sensitivities.

Latex Allergy Key Companies Latest Latex Allergy Companies Companies Update

July 2023: Following five years of development in Europe and two years in Canada, Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, today announced that HULIO® (adalimumab-fkjp) injection, a biosimilar to Humira® (adalimumab), is now available to patients in the United States. Biocon Biologics, a company that recently made its acquisition of the global biosimilars business of Viatris, has obtained numerous biosimilar approvals in more than one hundred countries worldwide, including the United States and Europe. As a result of acquiring the biosimilars division of Viatris, Biocon Biologics is now able to assist medical professionals and patients in the treatment of diabetes, cancer, and immunology with more accessible and cost-effective options. Biocon Biologics has reached a significant milestone with the introduction of HULIO®, its biosimilar adalimumab, in the United States.

July 2023: Celltrion Healthcare, a biopharmaceutical company based in South Korea, announced on Monday that it introduced Yuflyma, a biosimilar to the autoimmune disease treatment Humira, which contains adalimumab-aaty, into the United States market the day before. Humira is a blockbuster medication, with $18.6 billion, or 87%, of its $21.2 billion in global sales in the United States last year. The treatment, which is offered in both autoinjector and prefilled hypodermic configurations, has obtained indications in the United States for eight diseases, including ulcerative colitis, Crohn's disease, and rheumatoid arthritis. Yuflyma, a medication with a high concentration of 100 milligrams per milliliter that reduces the dosage by half compared to low-concentration alternatives, is devoid of the analgesic citrate.

List of Latex Allergy Companies Key companies in the market

Sanofi

Alcon Inc.

Dey Labs

Allerayde UK Ltd

Rocky Mountain Diagnostics

Allergy Hero

Novartis AG

Array

Nektar Therapeutics

BioPharma Inc

Merck

AstraZeneca

Latex Allergy Market Highlights:

Latex Allergy Market Size

Latex Allergy Market Trends

Latex Allergy Market Analysis

Latex Allergy Market Share

Latex Allergy Market Highlights:

Latex Allergy Market Trends

Latex Allergy Market Analysis

Latex Allergy Market Share

Latex Allergy Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.